Sustainability and Transformation Plans

Debate between Baroness Crawley and Lord O'Shaughnessy

Thursday 26th January 2017 Lords Chamber

[Lord O'Shaughnessy]

All 44 sustainability and transformation plans have now been published and are being scrutinised by NHS England, which is helping to ensure that they are as successful as possible. Operational plans will then come forward from April 2017 onwards.

[Baroness Crawley (Lab)]

My Lords, the sustainability and transformation plans have been widely criticised for not yet allowing adequate public or parliamentary scrutiny. Does the Minister agree with me that any future rationing of cancer drug treatment, for example, should receive the public scrutiny it deserves? In particular, will he intervene with NICE and the pharmaceutical company Roche to demand a rethink on the proposal to stop from next week the effective secondary breast cancer drug, Kadcyla, being available to women on the NHS?

[Lord O'Shaughnessy]

On public scrutiny, all the sustainability and transformation plans have had public involvement. They were published and consulted on. I do not recognise the picture that the noble Baroness paints in relation to cancer drugs. This Government created the cancer drugs fund in order specifically to fund innovative cancer drugs and bring them to market more quickly. She will know that decisions on availability and funding of drugs are properly taken by NICE on a clinical basis.